8/103 sources · 2 publishersUpdated Oct 8, 17:25 UTC
Option Care Health downgraded by analysts as CD&R and McKesson agree to acquire at $32.05 per share
Jefferies lowered Option Care Health (OPCH) to Hold from Buy and set a new price target of $32.05. Citizens also cut OPCH to Market Perform from Outperform. Both actions follow a cash acquisition agreement by CD&R and McKesson at $32.05 per share.
Why it matters
The downgrades reduce analyst support for OPCH and may pressure the stock despite the acquisition premium. The $32.05 price target aligns with the cash offer, indicating limited upside beyond the deal price.
Key facts
- 1Jefferies downgraded OPCH to Hold from Buy and set a price target of $32.05 per share. tipranks.com
- 2The downgrade follows an agreement by CD&R and McKesson to acquire OPCH for $32.05 per share in cash. tipranks.com
- 3Citizens analyst Constantine Davides downgraded OPCH to Market Perform from Outperform after the same acquisition agreement. tipranks.com
- 4Jefferies also reported a 35.91% year‑to‑date increase in OPCH stock and a 2.70% decline over the past five days. marketscreener.com
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.